Proteomics International is pleased to announce the third licensing deal for PromarkerD, with our world leading predictive test for diabetic kidney disease to be launched in the global diabetes hot spot of Mexico.
The exclusive deal with Patia Biopharma will see PromarkerD made available across Mexico to hospitals, clinics, government programs, and Carlos Slim Foundation programs.
